Andrea B. Smith - Apr 28, 2022 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
Director
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Apr 28, 2022
Transactions value $
$247,815
Form type
4
Date filed
5/2/2022, 06:01 PM
Previous filing
Apr 27, 2022
Next filing
Apr 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Purchase $248K +1.16K +107.51% $213.63 2.24K Apr 28, 2022 Direct F1
holding HCA Common Stock 82 Apr 28, 2022 By managed accounts F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $213.23 to $213.73, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The shares reported herein are held in fully managed accounts over which the reporting person does not have any investment authority. The reporting person disclaims beneficial ownership of the shares reported herein except to the extent of her pecuniary interest therein.